Skip to main content

MoneyWorks4Me

Marksans Pharma informs about newspaper publication

01 Jun 2022 Evaluate

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed that it enclosed Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2022 published today i.e. 1st June, 2022 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.70
Dr. Reddys Labs. 1385.25
Cipla 1409.25
Lupin 2014.80
Zydus Lifesciences 1220.90
View more..